| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082514 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | US20040082512 Drugs for treatment of inflammation/blood brain barrier degradation |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082504 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent |
| 04/29/2004 | US20040081686 Use of particle vectors in immunomodulation |
| 04/29/2004 | US20040081624 Mixture containing high volatility carrier; vaporization; mixing with air |
| 04/29/2004 | US20040079921 Gel; skin penetration enhancers; mixture of hydrotrope, amphiphile and solvent |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2771725A1 Solid preparation comprising a non-toxic base and a proton pump inhibitor |
| 04/29/2004 | CA2542507A1 Treatment of inflammatory bowel disease |
| 04/29/2004 | CA2503325A1 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | CA2502356A1 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | CA2502324A1 Glucagon - like peptide - 2 variants |
| 04/29/2004 | CA2502084A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 04/29/2004 | CA2501201A1 Gastric acid secretion inhibiting composition |
| 04/29/2004 | CA2475053A1 Treatment of microbial infections and associated gastrointestinal disorders with thymosin .beta.4 |
| 04/28/2004 | EP1413589A1 Polymers for oral use and compositions for oral use |
| 04/28/2004 | EP1413313A1 DIAGNOSIS AND TREATMENT OF INSULIN−DEPENDENT DIABETES MELLITUS AND INSULITIS |
| 04/28/2004 | EP1412501A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412379A2 Antigenic polypeptides |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1412363A1 Gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412355A1 New pyrazolo(3,4-d)pyrimidines inhibiting h. pylori infections |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411967A2 Blocking peptide for inflammatory cell secretion |
| 04/28/2004 | EP1411962A2 Monoclonal antibody therapy for pancreas cancer |
| 04/28/2004 | EP1411953A1 Methods and compositions for treatment of gastric diseases |
| 04/28/2004 | EP1411952A1 Use of at least one glycoinhibitor substance |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411900A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411780A1 Soluble roasted chicory with high inulin content |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1230237B1 Magnesium omeprazole |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1039892B1 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis |
| 04/28/2004 | EP1037539B1 Method for accelerating protein digestion rate and modified protein product |
| 04/28/2004 | EP0937045B1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 04/28/2004 | EP0913157B1 A composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 04/28/2004 | EP0719253B1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/28/2004 | CN1492923A 减毒的活疫苗 Attenuated live vaccine |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists |
| 04/28/2004 | CN1492764A Medicines for relieving intestinal disorders |
| 04/28/2004 | CN1492737A Functional agent for decomposing nicotine and method of preparing the same |
| 04/28/2004 | CN1491721A Oral prepn form of human interleukin 11 liposome |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1491716A Fingered citron particals for stomach ailment and its preparing method |
| 04/28/2004 | CN1491706A Soft capsule for removing blood stasis in chest and its preparing method |
| 04/28/2004 | CN1491703A Method for preventing motion syndrome and mask for preventing motion syndrome |
| 04/28/2004 | CN1491700A Medicine for treating children's diarrhea |
| 04/28/2004 | CN1491696A Composition for preventing and treating yellow dysentery of piglet |
| 04/28/2004 | CN1491695A Composition for preventing and treating pig's epidemic diarrhea |
| 04/28/2004 | CN1491686A Chinese medicine preparation for sobering up and liver protection and its preparing method |
| 04/28/2004 | CN1491684A Composition for treating hepatitis B |
| 04/28/2004 | CN1491668A Composition of stachyose and bee product |
| 04/28/2004 | CN1491667A Use of Euproctis pseudoconspersa in preparing medicine for treating diseases of gastrointestinal tract |
| 04/28/2004 | CN1491666A Chinese patented medicine for treating cholecystitis and its preparing method |
| 04/28/2004 | CN1491664A Composite medicinal preparation containing inosine matters |
| 04/28/2004 | CN1491642A Adhesive film agent and its preparing method |
| 04/28/2004 | CN1491589A Disease-proof health drink and its producing process |
| 04/28/2004 | CN1491569A Multiflower knotweed tuber tea |
| 04/28/2004 | CN1147579C Yang-invigorating wine and its preparing process |
| 04/28/2004 | CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite |
| 04/28/2004 | CN1147481C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 04/28/2004 | CN1147477C Novel allylthiopyridazine derivatives and process for preparing the same |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/28/2004 | CN1147298C Prevention and curing agent for hepatitis C |
| 04/27/2004 | US6727352 Methods of making macrolides |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |